TINDAMAX

LOE ApproachingSM

tinidazole

Mission Therapeutics
NDAORALTABLET
Approved
May 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2

Mechanism of Action

Pharmacologic Class:

Nitroimidazole Antimicrobial

Clinical Trials (2)

NCT00510614Phase 1Completed

Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study

Started Oct 2007
37 enrolled
Bacterial Vaginosis
NCT00229216Phase 3Completed

Treatment of Bacterial Vaginosis With Oral Tinidazole

Started Jan 2005
200 enrolled
Bacterial Vaginosis
Company
Mission Therapeutics
Mission Therapeutics
UK - Cambridge
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers